Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients
赞助:
University of Paris 5 - Rene Descartes
合作者:
信息的提供 (责任方):
Alexandre MALMARTEL，University of Paris 5 - Rene Descartes
| 追踪信息 | |||
|---|---|---|---|
| 首次提交日期 ICMJE | October 2, 2018 | ||
| 首次发布日期e ICMJE | October 5, 2018 | ||
| 最后更新发布日期 | October 5, 2018 | ||
| 预计研究开始日期 ICMJE | January 15, 2019 | ||
| 预计主要完成日期 | January 15, 2020 (主要结果测量的最终数据收集日期) | ||
| 目前主要观察指标 ICMJE |
Continuity of care[ Time Frame: over the past 1year ] Bice-Boxerman index, measuring continuity of care (from 0 to 1, 1 = good continuity of care) care pathway[ Time Frame: over the past 1 year ] the number of health care consultations with any physician (primary care, emergency department, hospitalisation), collected from the French national health insurance database |
||
| 原始主要观察测量 ICMJE | 与当前相同 | ||
| 目前的二级观察 ICMJE |
|
||
| 描述性信息 | |||
| 简略标题 ICMJE | Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients | ||
| 正式标题 ICMJE | Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients | ||
| 简要概况 | Chronic disease management is a public health problem that faces monitoring difficulties related to complex care pathways. This study will analyze the use of unscheduled or urgent care according to the continuity of care in multimorbid patients |
||
| 详细说明 | The prevalence of chronic diseases in the population is increasing significantly. It represents a new challenge for doctors and health authorities. However, patients often have at least two chronic diseases. These are referred to as "multimorbid" patients, whose continuity of care has not been well studied to date. This observational study evaluates the association between the continuity of care in multimorbid patients seen in general practice and their use of urgent healthcare, their quality of life and their burden of treatment. | ||
| 研究类型 ICMJE | Observational | ||
| 研究阶段 | |||
| 研究设计 ICMJE | 分配: 干预模型: 干预模型描述: 盲法: Observational 盲法描述: 主要目的: |
||
| 适用条件 ICMJE | |||
| 干预项目 ICMJE |
|
||
| 研究工具 |
|
||
| 招募信息 | |||
| 招募状态 ICMJE | Not yet recruiting | ||
| 预计入组 ICMJE |
600 | ||
| 原始预计入组 ICMJE | 与当前相同 | ||
| 预计研究完成日期 | June 15, 2020 | ||
| 预计主要完成日期 | January 15, 2020 (主要结果测量的最终数据收集日期) | ||
| 合格标准 ICMJE | Inclusion Criteria: - over 18 years of age, seen in consultation in the office by an investigating doctor, with a follow-up for more than 12 months in the office, presenting at least two chronic disease , having given their written consent to participate in the study Exclusion Criteria: - seen at home - unable to respond (cognitive problems or language barrier) | ||
| 性别 |
|
||
| 年龄 | 最小年龄：18 Years ，最大年龄：N/A | ||
| 接受健康的志愿者 | 没有 | ||
| 可入组国家 ICMJE | |||
| 管理信息 | 数据检测委员会 | No | |
| 研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
| IPD 共享声明 |
|
||
| 责任方 | Alexandre MALMARTEL，University of Paris 5 - Rene Descartes | ||
| 研究赞助商 ICMJE | University of Paris 5 - Rene Descartes | ||
| 合作者 ICMJE | |||
| 研究员 ICMJE |
|
||
| PRS 账户 | University of Paris 5 - Rene Descartes | ||
| 验证日期 | October 2018 | ||
|
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |
|||
请使用微信扫码报名
京公网安备 11010102003638号